# Sevoflurane Versus Propofol Anesthesia in Intracardiac Echocardiography-Guided Atrial Fibrillation Ablation

Study · id `cardio:ct-nct07877116` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07877116](<https://clinicaltrials.gov/study/NCT07877116>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07877116

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 124 participants.

## Technical summary

Registry record NCT07877116. Randomized; single masking; primary purpose other. Start 2026-10-01 (anticipated); primary completion 2027-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose other
- Phase: Phase 4
- Enrolled: 124 participants (planned count; ClinicalTrials.gov record NCT07877116, source copy `cardio:ctgov-nct07877116-2026-10-16`, retrieved 2026-10-26)
- Planned start: 2026-10-01 (anticipated) (ClinicalTrials.gov record NCT07877116, source copy `cardio:ctgov-nct07877116-2026-10-16`, retrieved 2026-10-26)
- Primary completion: 2027-04 (anticipated) (ClinicalTrials.gov record NCT07877116, source copy `cardio:ctgov-nct07877116-2026-10-16`, retrieved 2026-10-26)
- Completion: 2027-04 (anticipated) (ClinicalTrials.gov record NCT07877116, source copy `cardio:ctgov-nct07877116-2026-10-16`, retrieved 2026-10-26)
- Countries: Türkiye (ClinicalTrials.gov record NCT07877116, source copy `cardio:ctgov-nct07877116-2026-10-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07877116-2026-10-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Sevoflurane Versus Propofol Anesthesia in Intracardiac Echocardiography-Guided Atrial Fibrillation Ablation
- Condition: Persistent Atrial Fibrillation
- Intervention (Drug): Sevoflurane
- Intervention (Drug): propofol
- Lead sponsor: Hüseyin Ulaş Pinar
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: 7ac3ab7e6e971fc320d4b8a2e2196b3c16246e425e6dcc15aaf2954b14f13dc4
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
